These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11908224)

  • 41. Extrathymic tumors in patients with myasthenia gravis: a 35-year retrospective study.
    Wakata N; Sugimoto H; Nomoto N; Konno S; Nakazora H; Nemoto H; Karihara T
    Neurologist; 2006 Jan; 12(1):53-5. PubMed ID: 16547448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Study of anti-striational and anti-thyroid antibodies in patients with myasthenia gravis.
    Cojocaru IM; Cojocaru M; Muşuroi C
    Rom J Intern Med; 2000-2001; 38-39():111-20. PubMed ID: 15529579
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myasthenia gravis and premature ovarian failure.
    Ryan MM; Jones HR
    Muscle Nerve; 2004 Aug; 30(2):231-3. PubMed ID: 15266640
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pulmonary function tests and blood gases in worsening myasthenia gravis.
    Thieben MJ; Blacker DJ; Liu PY; Harper CM; Wijdicks EF
    Muscle Nerve; 2005 Nov; 32(5):664-7. PubMed ID: 16025526
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thymoma, myasthenia gravis, and other paraneoplastic syndromes.
    Tormoehlen LM; Pascuzzi RM
    Hematol Oncol Clin North Am; 2008 Jun; 22(3):509-26. PubMed ID: 18514130
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antisense treatment for myasthenia gravis: experience with monarsen.
    Sussman JD; Argov Z; McKee D; Hazum E; Brawer S; Soreq H
    Ann N Y Acad Sci; 2008; 1132():283-90. PubMed ID: 18567879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Response to therapy in myasthenia gravis with anti-MuSK antibodies.
    Evoli A; Bianchi MR; Riso R; Minicuci GM; Batocchi AP; Servidei S; Scuderi F; Bartoccioni E
    Ann N Y Acad Sci; 2008; 1132():76-83. PubMed ID: 18567856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity.
    Bedlack RS; Simel DL; Bosworth H; Samsa G; Tucker-Lipscomb B; Sanders DB
    Neurology; 2005 Jun; 64(11):1968-70. PubMed ID: 15955957
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Respiratory disorders during sleep and myasthenia].
    Gajdos P; Quera Salva MA
    Rev Neurol (Paris); 2001 Nov; 157(11 Pt 2):S145-7. PubMed ID: 11924028
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.
    Romi F; Skeie GO; Gilhus NE; Aarli JA
    Arch Neurol; 2005 Mar; 62(3):442-6. PubMed ID: 15767509
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A clinical and immunological study of a myasthenia gravis patient treated with infliximab.
    Kakoulidou M; Bjelak S; Pirskanen R; Lefvert AK
    Acta Neurol Scand; 2007 Apr; 115(4):279-83. PubMed ID: 17376128
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unravelling the pathogenesis of myasthenia gravis.
    Vincent A
    Nat Rev Immunol; 2002 Oct; 2(10):797-804. PubMed ID: 12360217
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
    Punga AR; Flink R; Askmark H; Stålberg EV
    Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multifocal paraneoplastic cortical encephalitis associated with myasthenia gravis and thymoma.
    Hammoud K; Kandimala G; Warnack W; Vernino S
    Arch Neurol; 2009 Nov; 66(11):1407-9. PubMed ID: 19901174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Immunosuppressive radiotherapy of myasthenia].
    Schmitt T; Michel D; Antoine JC; Schlienger M
    Presse Med; 1987 Apr; 16(12):592. PubMed ID: 2952969
    [No Abstract]   [Full Text] [Related]  

  • 58. Beneficial effect of tacrolimus on myasthenia gravis with thymoma.
    Mitsui T; Kunishige M; Ichimiya M; Shichijo K; Endo I; Matsumoto T
    Neurologist; 2007 Mar; 13(2):83-6. PubMed ID: 17351528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of myasthenia gravis acute exacerbations with intravenous immunoglobulin.
    Gajdos P; Chevret S
    Ann N Y Acad Sci; 2008; 1132():271-5. PubMed ID: 18096850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Unusual neurophysiological and immunological findings in myasthenia gravis: a case report.
    Scaioli V; Andreetta F; Mantegazza R
    J Peripher Nerv Syst; 2004 Jun; 9(2):92-7. PubMed ID: 15104696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.